Hepatitis B Therapy
New enzyme immunoassay for HBcrAg evaluated
Published in Hepatitis Weekly, August 18th, 2003
Additionally, they note, for monitoring lamivudine treatment response, HBV core-related antigen (HBcrAg) serves as a viral marker is independent of HBV DNA.
HBcrAg in 82 patients with chronic HBV infection and 167 HBV negative controls "was measured by CLEIA with monoclonal antibodies to hepatitis B e antigen (HBeAg) and hepatitis B core antigen (HBcAg), and HBV DNA was measured by transcription-mediated amplification assay (TMA) and in-house real-time detection polymerase chain reaction (RTD-PCR),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-08-18)
More Articles from Hepatitis Weekly
- Hepatitis C Virology
Viral internal ribosome entry site prevents inhibition of initiation by PKR - Viral Persistence
Peripheral blood dendritic cells appear to be a reservoir for HCV replication - Diagnostics
Rapid immunochromatographic assay for HBV screening gets thumbs up - Hepatitis C Therapy
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics - Hepatocellular Carcinoma
HBV frequently targets cellular genes involved in cell signaling - Immunology
Study finds additional evidence of unbalanced IFN systems in HCV infection - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
